The first patients enrolled in the LESS GERD trial have been implanted with the EndoStim device, a minimally invasive implant that uses neurostimulation to normalize esophageal function and provide long-term reflux control, the manufacturer announced.
Researchers performed these first implants at Dignity Health St. Joseph’s Hospital and Medical Center in Phoenix, Arizona, and at the Stanford University School of Medicine.
This activity is supported by an educational grant from Receptos.
Digestive Disease Week
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
©2017 Healio All Rights Reserved.